A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of ...
What causes autoimmune disease? A new study finds that somatic mutations in immune checkpoint genes like PDL1 trigger the ...
Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors One patient ...
Rheumatoid arthritis and hypothyroidism often occur together and cause similar symptoms such as fatigue. Here's what you need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results